Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers

A. M. Tsimberidou; H. Ma; C. Stewart; O. Schoor; D. Maurer; R. Mendrzyk; A. Satelli; J. Fritsche; G. Stephens; A. Mohamed; P. Hwu; C. Yee; C. Reinhardt; T. Weinschenk; K. Gharpure; A. Stungis; D. J. Vining; H. Singh; S. Walter; B. S. Andersson

doi:10.1093/annonc/mdy288.028

Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers

A. M. Tsimberidou, H. Ma, C. Stewart, O. Schoor, D. Maurer, R. Mendrzyk, A. Satelli, J. Fritsche, G. Stephens, A. Mohamed, P. Hwu, C. Yee, C. Reinhardt, T. Weinschenk, K. Gharpure, A. Stungis, D. J. Vining, H. Singh, S. Walter, B. S. Andersson

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii411
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy288.028
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy288.028

Cite this

Tsimberidou, A. M., Ma, H., Stewart, C., Schoor, O., Maurer, D., Mendrzyk, R., Satelli, A., Fritsche, J., Stephens, G., Mohamed, A., Hwu, P., Yee, C., Reinhardt, C., Weinschenk, T., Gharpure, K., Stungis, A., Vining, D. J., Singh, H., Walter, S., & Andersson, B. S. (2018). Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii411. https://doi.org/10.1093/annonc/mdy288.028

Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers. / Tsimberidou, A. M.; Ma, H.; Stewart, C. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii411.

Research output: Contribution to journal › Article › peer-review

Tsimberidou, AM, Ma, H, Stewart, C, Schoor, O, Maurer, D, Mendrzyk, R, Satelli, A, Fritsche, J, Stephens, G, Mohamed, A, Hwu, P, Yee, C, Reinhardt, C, Weinschenk, T, Gharpure, K, Stungis, A, Vining, DJ, Singh, H, Walter, S & Andersson, BS 2018, 'Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii411. https://doi.org/10.1093/annonc/mdy288.028

Tsimberidou AM, Ma H, Stewart C, Schoor O, Maurer D, Mendrzyk R et al. Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii411. doi: 10.1093/annonc/mdy288.028

@article{c4cb171980994f6f8889ba775adb2704,

title = "Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog{\textregistered} IMA101) in patients with relapsed and/or refractory solid cancers",

author = "Tsimberidou, {A. M.} and H. Ma and C. Stewart and O. Schoor and D. Maurer and R. Mendrzyk and A. Satelli and J. Fritsche and G. Stephens and A. Mohamed and P. Hwu and C. Yee and C. Reinhardt and T. Weinschenk and K. Gharpure and A. Stungis and Vining, {D. J.} and H. Singh and S. Walter and Andersson, {B. S.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy288.028",

language = "English (US)",

volume = "29",

pages = "viii411",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers

AU - Tsimberidou, A. M.

AU - Ma, H.

AU - Stewart, C.

AU - Schoor, O.

AU - Maurer, D.

AU - Mendrzyk, R.

AU - Satelli, A.

AU - Fritsche, J.

AU - Stephens, G.

AU - Mohamed, A.

AU - Hwu, P.

AU - Yee, C.

AU - Reinhardt, C.

AU - Weinschenk, T.

AU - Gharpure, K.

AU - Stungis, A.

AU - Vining, D. J.

AU - Singh, H.

AU - Walter, S.

AU - Andersson, B. S.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081529298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081529298&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy288.028

DO - 10.1093/annonc/mdy288.028

M3 - Article

C2 - 32137031

SN - 0923-7534

VL - 29

SP - viii411

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this